QualifyHQ Logo

Enso

ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.

Imwaqqfa fis-sena

2014

Dħul

$2.5M - $5.0M

Finanzjament

$108.8M

Ara kumpaniji simili

Qualify this Company in

minutes

Filwaqt li għodod oħra jaħlulek il-ħin, aħna ngħinuk tikkwalifika kumpaniji li jaqblu aħjar fi ftit minuti, biex il-pipeline tiegħek jibqa' b'saħħtu, it-tim tiegħek jibqa' produttiv, u d-deals jimxu aktar malajr.

Start free trial

Ibda l-Prova Bla Ħlas ta' 7 Ijiem